Federal Register-02-28317

Federal Register / Vol. 67, No.
216 / Thursday, November 7, 2002 / Notices 67871
Any such comments or objections Administration, United States and a review of the company’s
may be addressed, in quintuplicate, to Department of Justice, Washington, DC background and history. Therefore,
the Deputy Assistant Administrator, 20537, Attention: DEA Federal Register pursuant to 21 U.S.C. 823 and 28 CFR
Office of Diversion Control, Drug Representative (CCR), and must be filed 0.100 and 0.104, the Deputy Assistant
Enforcement Administration, United no later than (30 days from publication). Administrator, Office of Diversion
States Department of Justice, This procedure is to be conducted Control, hereby orders that the
Washington, DC 20537, Attention: DEA simultaneously with and independent application submitted by the above firm
Federal Register Representative (CCR), of the procedures described in 21 CFR for registration as a bulk manufacturer
and must be filed no later than January 1301.34(b), (c), (d), (e), and (f). As noted of the basic class of controlled substance
6, 2003. in a previous notice at 40 FR 43745–46 listed above is granted.
Dated: October 25, 2002. (September 23, 1975), all applicants for Dated: October 25, 2002.
registration to import basic class of any Laura M. Nagel,
Laura M. Nagel,
controlled substance in Schedule I or II Deputy Assistant Administrator, Office of
Deputy Assistant Administrator, Office of
are and will continue to be required to Diversion Control, Drug Enforcement
Diversion Control, Drug Enforcement
Administration. demonstrate to the Deputy Assistant Administration.
Administrator, Office of Diversion [FR Doc. 02–28316 Filed 11–6–02; 8:45 am]
[FR Doc. 02–28315 Filed 11–6–02; 8:45 am]
Control, Drug Enforcement BILLING CODE 4410–09–M
BILLING CODE 4410–09–M
Administration that the requirements
for such registration pursuant to 21
DEPARTMENT OF JUSTICE U.S.C. 958(a), 21 U.S.C. 823(a), and 21 DEPARTMENT OF JUSTICE
CFR 1311.42(a), (b), (c), (d), (e), and (f)
Drug Enforcement Administration are satisfied. Drug Enforcement Administration
Dated: October 25, 2002.
Importation of Controlled Substances; Manufacturer of Controlled
Laura M. Nagel, Substances Notice of Registration
Notice of Application
Pursuant to Section 1008 of the Diversion Control, Drug Enforcement By Notice dated April 11, 2002, and
Controlled Substances Import and Administration. published in the Federal Register on
Export Act (21 U.S.C. 958(i)), the [FR Doc. 02–28311 Filed 11–6–02; 8:45 am] April 26, 2002, (67 FR 20828),
Attorney General shall, prior to issuing BILLING CODE 4410–09–M Organichem Corporation, 33 Riverside
a registration under this Section to a Avenue, Rensselaer, New York 12144,
bulk manufacturer of a controlled made application by renewal to the
substance in Schedule I or II and prior DEPARTMENT OF JUSTICE Drug Enforcement Administration
to issuing a regulation under Section (DEA) to be registered as a bulk
1002(a) authorizing the importation of Drug Enforcement Administration manufacturer of the basic classes of
such a substance, provide controlled substances listed below:
Manufacturer of Controlled
manufacturers holding registrations for Substances; Notice of Registration Drug Schedule
the bulk manufacture of the substance
an opportunity for a hearing. By Notice dated April 11, 2002, and Amphetamine (1100) .................... II
Therefore, in accordance with Section published in the Federal Register on Pentobarbital (2270) ..................... II
1301.34 of Title 21, Code of Federal April 26, 2002, (67 FR 20828), Novartis Methylphenidate (1724) ................ II
Regulations (CFR), notice is hereby Pharmaceutical Corporation, 59 Route Meperidine (9230) ........................ II
given that on June 23, 2002, Noramco 10, East Hanover, New Jersey 07936,
Inc., 1440 Olympic Drive, Athens, made application by renewal to the The firm plans to manufacture bulk
Georgia 30601, made application by Drug Enforcement Administration products for distribution to its
renewal to the Drug Enforcement (DEA) to be registered as a bulk customers.
Administration to be registered as an manufacturer of methylphenidate No comments or objections have been
importer of phenylacetone (8501), a (1724), a basic class of controlled received. DEA has considered the
basic class of controlled substance listed substance listed in Schedule II. factors in Title 21, United States Code,
Schedule II. The firm plans to manufacture section 823(a) and determined that the
The firm plans to import finished product for distribution to its registration of Organichem Corporation
phenylacetone for the production of customers. to manufacture the listed controlled
amphetamine. DEA has considered the factors in substances is consistent with the public
Any manufacturer holding, or Title 21, United States Code, Section interest at this time. DEA has
applying for, registration as a bulk 823a and determined that the investigated Organichem Corporation to
manufacturer of this basic class of registration of Novartis Pharmaceutical ensure that the company’s registration is
controlled substance may file written Corporation to manufacture consistent with the public interest. The
comments on or objections to the methylphenidate is consistent with the investigation included inspection and
application described above and may, at public interest at this time. DEA has testing of the company’s physical
the same time, file a written request for investigated Novartis Pharmaceutical security systems, verification of the
a hearing on such application in Corporation on a regular basis to ensure company’s compliance with state and
accordance with 21 CFR 1301.43 in that the company’s continued local laws, and a review of the
such form as prescribed by 21 CFR registration is consistent with the public company’s background and history.
1316.47. interest. These investigations have Therefore, pursuant to 21 U.S.C. 823
Any such comments, objections, or included inspection and testing of the and 28 CFR 0.100 and 0.104, the Deputy
requests for a hearing may be addressed, company’s physical security systems, Assistant Administrator, Office of
in quintuplicate, to the Deputy Assistant audits of the company’s records, Diversion Control, hereby orders that
Administrator, Office of Diversion verification of the company’s the application submitted by the above
Control, Drug Enforcement compliance with state and local laws, firm for registration as a bulk
VerDate 0ct<31>2002 16:18 Nov 06, 2002 Jkt 200001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\07NON1.SGM 07NON1
67872 Federal Register / Vol. 67, No. 216 / Thursday, November 7, 2002 / Notices
manufacturer of the basic classes of controlled substances may file written (OMB) for review and approval in
controlled substances listed above is comments on or objections to the accordance with the Paperwork
granted. application described above and may, at Reduction Act of 1995 (Pub. L. 104–13,
Dated: October 25, 2002. the same time, file a written request for 44 U.S.C. Chapter 35). A copy of this
Laura M. Nagel, a hearing on such application in ICR, with applicable supporting
accordance with 21 CFR 1301.43 in documentation, may be obtained by
Diversion Control, Drug Enforcement such form as prescribed by 21 CFR calling the Department of Labor. To
Administration. 1316.47. obtain documentation, contact Darrin
[FR Doc. 02–28317 Filed 11–6–02; 8:45 am]
Any such comments, objections or King on (202) 693–4129 or e-Mail: King-
requests for a hearing may be addressed, Darrin@dol.gov.
BILLING CODE 4410–09–M
in quintuplicate, to the Deputy Assistant Comments should be sent to Office of
Administrator, Office of Diversion Information and Regulatory Affairs,
DEPARTMENT OF JUSTICE Control, Drug Enforcement Attn: OMB Desk Officer for Department
Administration, United States of Labor, Office of Management and
Drug Enforcement Administration Department of Justice, Washington, D.C. Budget, Room 10235, Washington, DC
20537, Attention: DEA Federal Register 20503 ((202) 395–7316), within 30 days
Importation of Controlled Substances; Representative (CCR), and must be filed from the date of this publication in the
Notice of Application no later than December 9, 2002. Federal Register.
This procedure is to be conducted The OMB is particularly interested in
Pursuant to section 1008 of the
simultaneously with and independent comments which:
Controlled Substances Import and
of the procedures described in 21 CFR • Evaluate whether the proposed
Export Act (21 U.S.C. 958(i)), the
1301.34(b), (c), (d), (e), and (f). As noted collection of information is necessary
Attorney General shall, prior to issuing
in a previous notice at 40 FR 43745–46 for the proper performance of the
a registration under this section to a
(September 23, 1975), all applicants for functions of the agency, including
bulk manufacturer of a controlled
registration to import the basic classes whether the information will have
substance in Schedule I or II and prior
of any controlled substances in practical utility;
to issuing a regulation under section
Schedule I or II are and will continue to • Evaluate the accuracy of the
1002(a) authorizing the importation of
be required to demonstrate to the agency’s estimate of the burden of the
such a substance, provide
Deputy Assistant Administrator, Office proposed collection of information,
manufacturers holding registrations for
of Diversion Control, Drug Enforcement including the validity of the
the bulk manufacture of the substance
Administration that the requirements methodology and assumptions used;
an opportunity for a hearing.
Therefore, in accordance with section for such registration pursuant to 21 • Enhance the quality, utility, and
1301.34 of Title 21, Code of Federal U.S.C. 958(a), 21 U.S.C. 823(a), and 21 clarity of the information to be
Regulations (CFR), notice is hereby CFR 1301.34(a), (b), (c), (d), (e), and (f) collected; and
given that on June 13, 2002, Research are satisfied. • Minimize the burden of the
Triangle Institute, Kenneth H. Davis, Jr., Dated: October 25, 2002. collection of information on those who
Hermann Building, East Institute Drive, Laura M. Nagel, are to respond, including through the
P.O. Box 12194, Research Triangle Park, Deputy Assistant Administrator, Office of use of appropriate automated,
North Carolina 27709, made application Diversion Control, Drug Enforcement electronic, mechanical, or other
by renewal to the Drug Enforcement Administration. technological collection techniques or
Administration to be registered as an [FR Doc. 02–28313 Filed 11–6–02; 8:45 am] other forms of information technology,
importer of the basic classes of BILLING CODE 4410–09–M e.g., permitting electronic submission of
controlled substances listed below: responses.
AGENCY: Women’s Bureau.
Drug Schedule DEPARTMENT OF LABOR Type of Review: Extension of a
currently approved collection.
Marihuana (7360) ................. I Office of the Secretary
Cocaine (9041) ..................... II Title: Women in Apprenticeship and
Nontraditional Occupations (WANTO)
Submission for OMB Review;
The firm plans to import small Act Grant application and Reporting
Comment Request
quantities of the listed controlled Requirements.
substances for the National Institute of October 31, 2002. OMB Number: 1225–0080.
Drug Abuse and other clients. The Department of Labor (DOL) has Frequency: Annually and Quarterly.
Any manufacturer holding, or submitted the following public Affected Public: Not-for-profit
applying for, registration as a bulk information collection request (ICR) to institutions.
manufacturer of these basic classes of the Office of Management and Budget Number of Respondents: 55.
Estimated Average re- Estimated an-

Requirement Frequency number of re- sponse time nual burden
sponses (hours) hours
Grant Application:
Previous Applicant ....................................... Annually .......................................................... 40 6 240
New Applicant ............................................. Annually .......................................................... 15 12 180
Quarterly Reports:
Previous Applicant ....................................... Quarterly ......................................................... 36 2 72
New Applicant ............................................. Quarterly ......................................................... 8 5 40
Final Report:
Previous Applicant ....................................... Annually .......................................................... 9 4 36
VerDate 0ct<31>2002 16:18 Nov 06, 2002 Jkt 200001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\07NON1.SGM 07NON1

Federal Register-02-28317

Diunggah oleh

Informasi Dokumen

Deskripsi Asli:

Hak Cipta

Format Tersedia

Bagikan dokumen Ini

Bagikan atau Tanam Dokumen

Opsi Berbagi

Apakah menurut Anda dokumen ini bermanfaat?

Apakah konten ini tidak pantas?

Hak Cipta:

Format Tersedia

Federal Register-02-28317

Diunggah oleh

Hak Cipta:

Format Tersedia

Federal Register / Vol. 67, No.

216 / Thursday, November 7, 2002 / Notices 67871

Estimated Average re- Estimated an-

Anda mungkin juga menyukai